Hepatitis C prevalence in injecting drug users in Europe, 1990-2007: impact of study recruitment setting (Q38471467)

3 September 2017

title

Hepatitis C prevalence in injecting drug users in Europe, 1990-2007: impact of study recruitment setting (English)

1 reference

3 September 2017

3

S J Hutchinson

1 reference

3 September 2017

M Rondy

1

1 reference

3 September 2017

L Wiessing

2

1 reference

3 September 2017

C Matheï

4

1 reference

3 September 2017

F Mathis

5

1 reference

3 September 2017

V Mravcik

6

1 reference

3 September 2017

L Norden

7

1 reference

3 September 2017

M Rosińska

8

1 reference

3 September 2017

O Scutelniciuc

9

1 reference

3 September 2017

B Suligoi

10

1 reference

3 September 2017

F Vallejo

11

1 reference

3 September 2017

M VAN Veen

12

1 reference

3 September 2017

M Kretzschmar

13

1 reference

3 September 2017

publication date

17 May 2012

1 reference

Epidemiology and Infection

3 September 2017

published in

1 reference

3 September 2017

volume

141

1 reference

3 September 2017

issue

3

1 reference

3 September 2017

page(s)

563-572

1 reference

Subpopulations of illicit drug users reached by targeted street outreach and respondent-driven sampling strategies: implications for research and public health practice

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0950268812000921

Accessing a diverse sample of injection drug users in San Francisco through respondent-driven sampling

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268812000921

Respondent-Driven Sampling: A New Approach to the Study of Hidden Populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268812000921

Effectiveness of respondent-driven sampling for recruiting drug users in New York City: findings from a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268812000921

Hepatitis C virus infection among injecting drug users in the Czech Republic -- prevalence and associated factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268812000921

HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268812000921

Associations between availability and coverage of HIV-prevention measures and subsequent incidence of diagnosed HIV infection among injection drug users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268812000921

Seroprevalence of hepatitis C markers among intravenous drug users in western European countries: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268812000921

Monitoring hepatitis C virus infection among injecting drug users in the European Union: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268812000921

Decline in HIV incidence and injecting, but not in sexual risk behaviour, seen in drug users in Amsterdam: a 19-year prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268812000921

Management of occupational exposures to blood-borne viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268812000921

Epidemiology of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268812000921

Measuring risk of HIV and HCV among injecting drug users in the Russian Federation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268812000921

Do needle exchange programmes increase the spread of HIV among injection drug users?: an investigation of the Vancouver outbreak.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268812000921

Substance abuse treatment entry, retention, and outcome in women: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268812000921

Low and stable prevalence of HIV among drug injectors in Glasgow

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268812000921

Factors associated with injecting risk behaviour among serial community-wide samples of injecting drug users in Glasgow 1990-94: implications for control and prevention of blood-borne viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268812000921

Prevalence of hepatitis C virus infection among injecting drug users in Glasgow 1990-1996: are current harm reduction strategies working?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268812000921

Evaluating recruitment among female sex workers and injecting drug users at risk for HIV using respondent-driven sampling in Estonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268812000921

Continued high prevalence of HIV, HBV and HCV among injecting and noninjecting drug users in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0950268812000921

inferred from DOI database lookup

7 January 2021

based on heuristic

Sharing of drug preparation equipment as a risk factor for hepatitis C

1 reference

https://api.crossref.org/works/10.1017%2FS0950268812000921

inferred from DOI database lookup

7 January 2021

based on heuristic

Prevalence and correlates of infection with human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among drug users in Italy: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1017%2FS0950268812000921

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1017/S0950268812000921

1 reference

3 September 2017

1 reference